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Human T-cell leukemia virus type 1 (HTLV-1) is a tumorigenic retrovirus that infects an 
estimated 15-20 million people worldwide. HTLV-1 is responsible for an aggressive T-
cell malignancy termed adult T-cell leukemia/lymphoma (ATLL). The incidence of 
disease associated with HTLV-1 infection is 2-6% over the lifetime of an infected 
individual, with symptoms taking up to 3-4 decades to present. Despite the long clinical 
latency period, HLTV-1-associated malignancies are chemotherapy resistant and the 
median survival time is <1 year. The detailed mechanism of how HTLV-1 transforms 
cells is still unknown, but several studies have indicated that two viral factors, Tax and 
HBZ, are individually linked to oncogenic transformation. However, the interplay 
between Tax and HBZ in the transformation process is unknown. Herein, we 
investigated the relationship between Tax and HBZ using a dual-inducible lentiviral 
expression system. Tax and HBZ cDNAs were cloned into the cumate-inducible and 
doxycycline-inducible expression vectors, respectively. These vectors were transduced 
into CTLL-2 cells and stable cellular clones were selected using drug resistance and 
single cell dilution. Clones that responded best to drug induction (as measured by 
mRNA levels and protein functionality) were selected for further experiments. Using the 
established CTLL-2 T-cell transformation assay, we sought to determine whether the 
presence of HBZ and Tax drives these cells from an IL-2-dependent to independent 
growth, a characteristic indicative of cellular transformation.  Our results indicate that 
both Tax and HBZ enhance transformation. Ultimately, our work will provide better 
insight into the transformation landscape of T-cells in humans and the molecular 





Human T-cell leukemia virus type 1 (HTLV-1) is a retrovirus, notable for its ability 
to cause adult T-cell leukemia/lymphoma (ATLL) in a small percentage of infected 
individuals after a long clinical latency period of 3-4 decades (Green et al. 2010). 
Specifically, ATLL is a  disease in which T-cells of the immune system (primarily T 
helper cells) become cancerous. The exact mechanism of how this occurs is still 
unknown, but several key studies from our lab and others have suggested the 
involvement of two viral factors in this process: Tax and HBZ. 
Tax is a viral transcriptional activator expressed early in viral infection (Green et 
al. 2010). This viral protein activates transcription of the viral genome and various 
cellular pathways involved in cellular proliferation. Previous published work has long 
established Tax as a viral oncogene - transforming cells through a variety of 
mechanisms including chromosomal instability (Jin et al. 1998), down-regulation of DNA 
repair mechanisms (Jeang et al. 1990), activation of cyclin-dependent kinases (Haller et 
al. 2000), deregulation of the NF-κΒ (Iha et al. 2003) and Akt signaling pathways 
(Peloponese et al. 2006), and silencing of the tumor suppressor protein p53 (Pise-
Masison et al. 2000). It is also important to note that Tax serves as the primary viral 
antigen which is recognized by the host’s immune system. Quite often, genetic and 
epigenetic inactivation of the Tax gene through mutations, promoter hypermethylation, 
and promoter deletion arise as the disease progresses to promote continual viral 
persistence (Matsuoka et al. 2007). 
  HTLV-1 basic leucine zipper factor (HBZ) is a modulator of both viral and cellular 




antisense genome strand/3’ end of the provirus (Figure 1) (Matsuoka et al. 2007). Tax 
initially activates the transcription of HBZ, but the expression of Tax and HBZ are 
inversely proportional due to HBZ’s ability to enhance the expression of PDLIM-2, a 
protein that promotes the degradation of Tax. HBZ also competes with Tax for basal 
cellular transcription factors such as CREB and p300 (Green et al. 2010). This is viewed 
as a viral adaptation for survival since Tax is highly immunogenic. Interestingly, in 
approximately 60% of ATLL cases, Tax is absent. However, hbz RNA is found in every 
ATLL patient and HTLV-1-infected cell line (Green et al. 2010). This is because the 
promoter driving hbz expression, the 3′ long terminal repeat (LTR), remains intact and is 
unmethylated at all stages of ATLL development, suggesting that the 3′ LTR has a 
critical role in maintenance of HTLV-1-mediated disease (Matsuoka et al. 2007). In 
summary, HTLV-1 has evolved where after Tax has initiated transformation, it is highly 
downregulated or even deleted to avoid detection by the immune system. There are 
currently no known HBZ specific cytotoxic T lymphocytes. Studies have shown that HBZ 
is not only a transcriptional activator, but is also important for the persistence of viral 
infection in late stages of ATLL development since HBZ knockout virus show 
significantly reduced tumor formation in animals (Green et al. 2010). Other studies have 
also suggested that hbz RNA, and not the HBZ protein, promotes T-cell proliferation 
due to RNA secondary structure (Matsuoka et al. 2007). 
 
 
 Figure 1. Genomic map of the HTLV-1 provirus. Tax is transcribed from the sense strand of the 
provirus along with many other structural, enzymatic, and accessory viral genes. HBZ is the only gene 




Problem identification and justification 
Overall, there is well-established evidence suggesting Tax and HBZ are 
individually linked to oncogenic transformation induced by HTLV-1. However, it is 
unclear if a relationship between Tax and HBZ in this transformation process occurs. 
The current theory within the field is that Tax initiates the transformation process, while 
HBZ provides the maintenance function. The purpose of this study is to gain a better 
understanding of the interplay between Tax and HBZ during T-cell transformation. Tax 
and HBZ are both expressed concurrently in a newly infected cell and therefore can 
affect the activities of each other. Altogether, our work will lead to better insight into the 
HTLV-1-mediated transformation process of T-cells and provide a better understanding 
towards therapies and treatments for ATLL. We hypothesize that the interplay between 
Tax and HBZ will enhance T-cell transformation and ultimately facilitate HTLV-1 
pathogenesis. 
MATERIALS AND METHODS 
The relationship between Tax and HBZ was investigated by using a dual-
inducible expression system in the IL-2-dependent murine T-cell line, CTLL-2. Tax and 
HBZ cDNAs were cloned into cumate-inducible and doxycycline-inducible expression 
vectors, respectively.  
Overview of the Tet-ON HBZ inducible system 
In the presence of doxycycline, Tet-On 3G serves as a transactivator protein 
driving the transcription of hbz RNA (Figure 2). This induction system is useful in 




transcription factors so it is virtually silent in the absence of doxycycline. Expression 







Overview of the cumate Tax inducible system 
     The CymR repressor binds to the cumate operator sequences with high affinity 
preventing any transcription of downstream genes (Figure 3). However, repression is 
alleviated through the addition of Cumate (a non-toxic, small molecule that binds to 
CymR) which leads to the transcription of tax mRNA. Similar to the Tet system, 









Figure 3. Cumate Tax inducible system. In the presence of cumate, the CymR repressor is 
alleviated from the CMV5 promoter and allows transcription of Tax mRNA. (Figure modified from 
Clontech). 
Figure 2. Tet-ON HBZ inducible system. In the presence of doxycycline, the transactivator protein 





Construction of the stable dual-inducible CTLL-2 cell line 
 Once successful cloning of Tax and HBZ cDNAs into the dual-inducible 
expression systems was completed, these lentiviral plasmids were integrated into the 
genome of the IL-2-dependent murine T-cell line, CTLL-2. This process first involves the 
transfection of lentiviral plasmids containing the two dual-inducible vectors, along with 
retroviral packaging components, into the adherent endothelial cell line, 293T (Figure 4). 
The cellular machineries of these cells then package the lentiviral components into 




infectious virus. Supernatant from these cells (containing secreted lentivirus) was 
collected and concentrated using ultracentrifugation over a sucrose gradient. Infectious 
lentiviral particles were then added to CTTL-2 cells and a spin inoculation was 
performed to ensure efficient transduction of target cells. Transduced cells were treated 
with antibiotic selection (hygromycin, G418, puromycin) after 3 days to select for cells 
with the dual-inducible integrated DNA vectors. A heterozygous population of CTTL-2 
cells was then cultured containing the newly added dual-inducible system. Genetic 
variation was minimized through a single-cell isolation technique that cultures a 
homogenous cell line from a single CTTL-2 clone.  
RESULTS 
Induction of the dual-inducible CTLL-2 cell line 
 Two common molecular biology techniques used to verify induction of the dual-
inducible expression include reverse transcriptase PCR (RT-PCR), a semi-quantitative 
method to quantitate RNA levels, and western blot analysis, which detects the level of a 







Figure 5. Verification of the dual-inducible expression. A) CTLL-2 dual-inducible cells were treated 
with titrating amounts of cumate for 24h. Total RNA was isolated followed by reverse transcription and 
PCR analysis of tax gene expression. B) CTLL-2 dual-inducible cells were treated with 30 µg/mL of 
cumate and 100 ng/mL of doxycycline, where indicated, for 24h. Cells were lysed and protein 





Testing Tax and HBZ functionality in dual-inducible cells 
To verify the functionality of the dual-inducible gene expression we utilize a 
luciferase-based reporter gene assay (Figure 6). Tax associates with and activates 
transcription from the viral LTR promoter through interactions with cellular transcription 
factors, such as CREB. HBZ represses Tax-mediated LTR-activation by competitive 
binding to these same cellular transcription factors. Therefore, we can use an LTR-
luciferase reporter construct to measure both Tax-activation and HBZ-mediated 













Cellular viability in the presence of Tax and HBZ 
      CTLL-2 cells require addition of exogenous IL-2 to proliferate and remain viable in 
tissue culture. Continual growth in the absence of IL-2 is indicative of cellular 
transformation in CTLL-2 cells. We can use this property to measure the effects of Tax 
and HBZ on cellular transformation. This process involves the removal of IL-2 from 
media in tissue culture. Once IL-2 has been removed, we then plate equal numbers of 
Figure 6. Relative LTR-luciferase activity in CTLL-2 dual-inducible cells. Dual-inducible CTLL-2 
cells were treated with 30 µg/mL of cumate and 100 ng/mL of doxycycline, where indicated, for 24h. 
Cells were lysed in passive lysis buffer and firefly luciferase activity was measured using a luminometer. 
LTR-driven luciferase activity is shown relative to protein concentration. Addition of cumate (Tax) 
activates LTR-luciferase activity, while addition of doxycycline and cumate (Tax and HBZ) repress LTR-




cells under varying concentrations of drug; Tax alone, HBZ alone, or Tax and HBZ. The 
number of live cells in each condition were enumerated daily (Figure 7). This method 












 The literature has established the oncogenic potential of both Tax and HBZ, 
providing evidence to their contribution in ATLL development. However, in a newly 
infected cell the expression of multiple viral factors occurs concurrently and thus can 
influence one another. Therefore, we hypothesized that the interplay between Tax and 
HBZ ultimately enhances T-cell transformation and eventual ATLL development. To test 
this hypothesis, we used a dual-inducible  lentiviral expression vectors that allows us to 
Figure 7. IL-2-independent transformation assay. CTLL-2 inducible cells were treated with 10 µg/mL 
of cumate (+), 30 µg/mL of cumate (++), and/or 100 ng/mL of doxycycline in the absence of IL-2. Live 




control individual levels of Tax and HBZ within the cell.  We successfully cloned Tax and 
HBZ cDNAs into cumate- and doxycycline-inducible lentiviral vectors, respectively 
(Figures 2-3). The dual-inducible lentiviral vectors were then transduced into CTLL-2 
cells and stable cell lines were selected (Figure 4). Induction of Tax and HBZ in 
response to cumate and doxycycline was verified using RT-PCR analysis and 
immunoblotting (Figure 5). Functionality of the induced Tax and HBZ proteins was then 
further verified using an LTR-driven luciferase construct (Figure 6). Finally, our data has 
suggested that the presence of both Tax and HBZ enhanced cellular viability in CTLL-2 
cells using our IL-2-independence transformation assay (Figure 7).   
 Future experiments will measure the levels of Tax and HBZ induced in CTLL-2 
cells in response to titrating amounts of cumate and doxycycline. After this has been 
completed, we can then begin to compare these levels to HTLV-1-transformed cell 
lines. This will help us to determine the optimal range of cumate and doxycycline for use 
in our IL-2-independence transformation assays and ensure physiologic levels of Tax 
and HBZ. This will also enable us to examine any potential leakiness of our dual-
inducible system. After fully characterizing the dual-inducible expression system, we 
can then begin to use optimized levels of cumate and doxycycline to generate IL-2-
independent cell lines. These cell lines can then be tested for their dependence on Tax 
and/or HBZ by removing cumate and doxycycline. Microarray analysis will also be used 
to examine the cellular expression profile of IL-2-independent cell lines identifying the 
key cellular pathways involved in transformation. Ultimately, our work will provide better 




pathogenesis of ATLL development with the ultimate goal to identify a therapeutic that 
targets critical pathways and will block cancerous cell growth. 
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